X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10347) 10347
Book Review (1828) 1828
Publication (624) 624
Magazine Article (32) 32
Conference Proceeding (20) 20
Book Chapter (14) 14
Newsletter (5) 5
Web Resource (3) 3
Book / eBook (2) 2
Dissertation (2) 2
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9204) 9204
index medicus (9084) 9084
male (6018) 6018
piperazines - therapeutic use (5482) 5482
piperazines - adverse effects (5062) 5062
female (4369) 4369
middle aged (3802) 3802
adult (3530) 3530
aged (2428) 2428
piperazines - administration & dosage (2419) 2419
imatinib mesylate (2216) 2216
treatment outcome (2103) 2103
piperazines - pharmacology (2044) 2044
pharmacology & pharmacy (1954) 1954
sildenafil citrate (1893) 1893
benzamides (1801) 1801
animals (1702) 1702
pyrimidines - therapeutic use (1440) 1440
psychiatry (1435) 1435
pyrimidines - adverse effects (1311) 1311
oncology (1291) 1291
antipsychotic agents - adverse effects (1172) 1172
abridged index medicus (1139) 1139
antipsychotic agents - therapeutic use (1117) 1117
dose-response relationship, drug (1111) 1111
antineoplastic agents - therapeutic use (1076) 1076
double-blind method (1076) 1076
aripiprazole (1064) 1064
adolescent (1046) 1046
purines (1042) 1042
sulfones (1041) 1041
drug therapy (1009) 1009
erectile dysfunction - drug therapy (937) 937
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (934) 934
antineoplastic agents - adverse effects (926) 926
sildenafil (911) 911
double-blind (823) 823
hematology (819) 819
quinolones - therapeutic use (771) 771
schizophrenia - drug therapy (756) 756
care and treatment (742) 742
time factors (736) 736
quinolones - adverse effects (731) 731
efficacy (725) 725
schizophrenia (718) 718
piperazines - pharmacokinetics (707) 707
rats (695) 695
neurosciences (692) 692
clinical trials as topic (690) 690
imatinib (689) 689
drug therapy, combination (676) 676
pyrimidines - administration & dosage (659) 659
young adult (657) 657
erectile dysfunction (652) 652
therapy (646) 646
phosphodiesterase inhibitors - therapeutic use (634) 634
research (610) 610
medicine & public health (599) 599
aged, 80 and over (593) 593
analysis (591) 591
clinical neurology (585) 585
medicine, general & internal (579) 579
safety (565) 565
chronic myelogenous leukemia (562) 562
risk factors (562) 562
sulfones - therapeutic use (562) 562
thiazoles - therapeutic use (559) 559
mice (558) 558
cancer (549) 549
drug administration schedule (541) 541
urology & nephrology (534) 534
administration, oral (533) 533
thiazoles - adverse effects (525) 525
phosphodiesterase inhibitors - adverse effects (517) 517
chronic myeloid-leukemia (509) 509
cardiac & cardiovascular systems (507) 507
drug interactions (502) 502
prasugrel hydrochloride (495) 495
protein kinase inhibitors - therapeutic use (495) 495
follow-up studies (488) 488
purines - therapeutic use (457) 457
clinical trials (456) 456
prospective studies (443) 443
impotence (427) 427
antineoplastic agents - administration & dosage (412) 412
dosage and administration (408) 408
protein kinase inhibitors - adverse effects (405) 405
child (403) 403
health aspects (403) 403
chronic myeloid leukemia (402) 402
vasodilator agents - therapeutic use (402) 402
sulfones - adverse effects (400) 400
randomized controlled trials as topic (395) 395
protein-tyrosine kinases - antagonists & inhibitors (393) 393
antipsychotic agents - administration & dosage (374) 374
internal medicine (369) 369
psychiatric status rating scales (366) 366
ticlopidine - analogs & derivatives (366) 366
pharmacokinetics (362) 362
pyrimidines - pharmacology (348) 348
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9645) 9645
German (185) 185
French (138) 138
Japanese (113) 113
Chinese (66) 66
Spanish (61) 61
Russian (38) 38
Dutch (22) 22
Italian (22) 22
Hungarian (20) 20
Danish (16) 16
Polish (16) 16
Norwegian (12) 12
Swedish (12) 12
Czech (5) 5
Hebrew (5) 5
Portuguese (5) 5
Finnish (4) 4
Romanian (4) 4
Bulgarian (3) 3
Croatian (1) 1
Lithuanian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American Academy of Child & Adolescent Psychiatry, ISSN 0890-8567, 2015, Volume 54, Issue 9, pp. 718 - 727.e3
Objective Second-generation antipsychotic (SGA) effects in youth were monitored to quantify extrapyramidal side effects (EPS) and to identify risk profiles for... 
Pediatrics | Psychiatry | extrapyramidal | second-generation antipsychotic | parkinsonism | dyskinesia | youth | PSYCHIATRY | PSYCHOLOGY, DEVELOPMENTAL | ONSET SCHIZOPHRENIA | SCHIZOAFFECTIVE DISORDER | BIPOLAR I DISORDER | OPEN-LABEL | SIMPSON-ANGUS SCALE | ATYPICAL ANTIPSYCHOTICS | ADOLESCENT SCHIZOPHRENIA | LONG-TERM SAFETY | DOUBLE-BLIND | PEDIATRICS | PLACEBO-CONTROLLED TRIAL | Multivariate Analysis | Prospective Studies | Akathisia, Drug-Induced - epidemiology | Antipsychotic Agents - adverse effects | Humans | Male | Thiazoles - therapeutic use | Thiazoles - adverse effects | Aripiprazole - adverse effects | Risperidone - therapeutic use | Antipsychotic Agents - therapeutic use | Mental Disorders - classification | Aripiprazole - therapeutic use | Risperidone - adverse effects | Female | Parkinson Disease, Secondary - chemically induced | Drug Therapy, Combination | Child | New York | Parkinson Disease, Secondary - epidemiology | Quetiapine Fumarate - adverse effects | Dyskinesia, Drug-Induced - epidemiology | Piperazines - therapeutic use | Piperazines - adverse effects | Quetiapine Fumarate - therapeutic use | Regression Analysis | Mental Disorders - drug therapy | Adolescent | Benzodiazepines - adverse effects | Benzodiazepines - therapeutic use | Medical treatment | Risk factors | Parkinsons disease | Child & adolescent psychiatry | Index Medicus
Journal Article
Cell Cycle, ISSN 1538-4101, 05/2012, Volume 11, Issue 9, pp. 1851 - 1861
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 20, pp. 1925 - 1936
Journal Article
Journal Article
The Cochrane database of systematic reviews, ISSN 1469-493X, 10/2018, Volume 10, Issue 10, pp. CD007360 - CD007360
Background Benign prostatic hyperplasia (BPH) is a common condition in ageing men that may cause lower urinary tract symptoms (LUTS). Treatment aims are to... 
Naphthalenes [adverse effects; therapeutic use] | 75 MG | EFFICACY | Prostatic Hyperplasia [complications] | STORAGE SYMPTOM | SEXUAL FUNCTION | CLINICAL PROGRESSION | Randomized Controlled Trials as Topic | MEDICINE, GENERAL & INTERNAL | OVERACTIVE BLADDER | Sulfonamides [adverse effects; therapeutic use] | Piperazines [adverse effects; therapeutic use] | ALPHA-ADRENOCEPTOR ANTAGONISTS | Adrenergic alpha-Antagonists [adverse effects; therapeutic use] | Prostatism [drug therapy; etiology] | TAMSULOSIN HYDROCHLORIDE | ALPHA-1 BLOCKERS | HEALTH-STATUS | Benzilates - adverse effects | Naphthalenes - adverse effects | Benzilates - therapeutic use | Humans | Adrenergic alpha-Antagonists - therapeutic use | Male | Prostatic Hyperplasia - complications | Prostatism - drug therapy | Urological Agents - adverse effects | Adrenergic alpha-Antagonists - adverse effects | Ethamsylate - therapeutic use | Lower Urinary Tract Symptoms - drug therapy | Lower Urinary Tract Symptoms - etiology | Ethamsylate - adverse effects | Urological Agents - therapeutic use | Prostatism - etiology | Tamsulosin - adverse effects | Tamsulosin - therapeutic use | Piperazines - therapeutic use | Piperazines - adverse effects | Indoles - adverse effects | Sulfonamides - therapeutic use | Quality of Life | Sulfonamides - adverse effects | Indoles - therapeutic use | Plant Extracts - therapeutic use | Drug Combinations | Naphthalenes - therapeutic use | Plant Extracts - adverse effects | Index Medicus
Journal Article
Neuropharmacology, ISSN 0028-3908, 08/2013, Volume 71, pp. 83 - 97
Serotonin (5-HT) is a neurotransmitter that is involved in many behavioral functions, including the organization of defense, and its putative pathological... 
Fear | Zebrafish | Anxiety | Serotonin | Scototaxis | Geotaxis | 5-HYDROXYTRYPTAMINE RELEASE | RAT | 5-HT1A RECEPTOR ANTAGONISTS | REUPTAKE INHIBITORS | DORSAL RAPHE | ADULT ZEBRAFISH | ELEVATED PLUS-MAZE | T-MAZE | NEUROSCIENCES | IN-VIVO | PHARMACOLOGY & PHARMACY | BRAIN | Anti-Anxiety Agents - administration & dosage | Fenclonine - administration & dosage | Spiro Compounds - therapeutic use | Anxiety - drug therapy | Piperidones - therapeutic use | Serotonin - chemistry | Brain - metabolism | Pyridines - adverse effects | Fenclonine - adverse effects | Behavior, Animal - drug effects | Hyperkinesis - chemically induced | Neurons - metabolism | Serotonin 5-HT1 Receptor Antagonists - administration & dosage | Anti-Anxiety Agents - therapeutic use | Buspirone - therapeutic use | Fluoxetine - adverse effects | Disease Models, Animal | Pyridines - administration & dosage | Nerve Tissue Proteins - agonists | Piperazines - therapeutic use | Piperazines - adverse effects | Extracellular Fluid - drug effects | Brain - drug effects | Serotonin Uptake Inhibitors - administration & dosage | Fluoxetine - administration & dosage | Piperazines - administration & dosage | Fenclonine - therapeutic use | Spiro Compounds - administration & dosage | Piperidones - adverse effects | Hyperkinesis - metabolism | Spiro Compounds - adverse effects | Dose-Response Relationship, Drug | Buspirone - administration & dosage | Protein Isoforms - metabolism | Protein Isoforms - agonists | Anti-Anxiety Agents - adverse effects | Buspirone - adverse effects | Fluoxetine - therapeutic use | Neurons - drug effects | Anxiety - metabolism | Pyridines - therapeutic use | Nerve Tissue Proteins - antagonists & inhibitors | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Serotonin 5-HT1 Receptor Agonists - therapeutic use | Serotonin 5-HT1 Receptor Agonists - adverse effects | Serotonin 5-HT1 Receptor Antagonists - adverse effects | Nerve Tissue Proteins - metabolism | Piperidones - administration & dosage | Extracellular Fluid - metabolism | Serotonin 5-HT1 Receptor Antagonists - therapeutic use | Animals | Serotonin - metabolism | Serotonin 5-HT1 Receptor Agonists - administration & dosage | Anxiety - chemically induced | Protein Isoforms - antagonists & inhibitors | Phenols | Buspirone hydrochloride | Fluoxetine | Index Medicus
Journal Article